These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25070726)

  • 1. Retinal pathology detected by optical coherence tomography in an animal model of Parkinson's disease.
    Schneider JS; Ault ME; Anderson DW
    Mov Disord; 2014 Oct; 29(12):1547-51. PubMed ID: 25070726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical coherence tomography as a tool to evaluate retinal changes in Parkinson's disease.
    Mailankody P; Battu R; Khanna A; Lenka A; Yadav R; Pal PK
    Parkinsonism Relat Disord; 2015 Oct; 21(10):1164-9. PubMed ID: 26297381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a prediction formula of Parkinson disease severity by optical coherence tomography.
    Jiménez B; Ascaso FJ; Cristóbal JA; López del Val J
    Mov Disord; 2014 Jan; 29(1):68-74. PubMed ID: 24458320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photoreceptor layer thinning in idiopathic Parkinson's disease.
    Roth NM; Saidha S; Zimmermann H; Brandt AU; Isensee J; Benkhellouf-Rutkowska A; Dornauer M; Kühn AA; Müller T; Calabresi PA; Paul F
    Mov Disord; 2014 Aug; 29(9):1163-70. PubMed ID: 24789530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal nerve fiber layer structure abnormalities in schizophrenia and its relationship to disease state: evidence from optical coherence tomography.
    Lee WW; Tajunisah I; Sharmilla K; Peyman M; Subrayan V
    Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7785-92. PubMed ID: 24135757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical coherence tomography in Parkinson's disease: is the retina a biomarker?
    Lee JY; Ahn J; Kim TW; Jeon BS
    J Parkinsons Dis; 2014; 4(2):197-204. PubMed ID: 24518436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of spectral-domain optical coherence tomography determined ganglion cell complex parameters and disease severity in Parkinson's disease.
    Bayhan HA; Aslan Bayhan S; Tanık N; Gürdal C
    Curr Eye Res; 2014 Nov; 39(11):1117-22. PubMed ID: 24655112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis.
    Zaveri MS; Conger A; Salter A; Frohman TC; Galetta SL; Markowitz CE; Jacobs DA; Cutter GR; Ying GS; Maguire MG; Calabresi PA; Balcer LJ; Frohman EM
    Arch Neurol; 2008 Jul; 65(7):924-8. PubMed ID: 18625859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility of peripapillary retinal nerve fiber layer and macular retinal thickness measurements using optical coherence tomography.
    Hsu SY; Tung IC; Sheu MM; Tsai RK
    Kaohsiung J Med Sci; 2006 Sep; 22(9):447-51. PubMed ID: 17000445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of retinal nerve fiber layer and macular thickness measurements in healthy Taiwanese individuals using optical coherence tomography (Stratus OCT).
    Hsu SY; Tsai RK
    J Glaucoma; 2008; 17(1):30-5. PubMed ID: 18303381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choroidal thinning as a new finding in Alzheimer's disease: evidence from enhanced depth imaging spectral domain optical coherence tomography.
    Gharbiya M; Trebbastoni A; Parisi F; Manganiello S; Cruciani F; D'Antonio F; De Vico U; Imbriano L; Campanelli A; De Lena C
    J Alzheimers Dis; 2014; 40(4):907-17. PubMed ID: 24577467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of peripapillary retinal nerve fiber layer thickness in patients with vitamin B12 deficiency using spectral domain optical coherence tomography.
    Türkyılmaz K; Öner V; Türkyılmaz AK; Kırbaş A; Kırbaş S; Şekeryapan B
    Curr Eye Res; 2013 Jun; 38(6):680-4. PubMed ID: 23317171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal thinning and correlation with functional disability in patients with Parkinson's disease.
    Satue M; Seral M; Otin S; Alarcia R; Herrero R; Bambo MP; Fuertes MI; Pablo LE; Garcia-Martin E
    Br J Ophthalmol; 2014 Mar; 98(3):350-5. PubMed ID: 24276697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo exploration of retinal nerve fiber layer morphology in Parkinson's disease patients.
    Visser F; Vermeer KA; Ghafaryasl B; Vlaar AMM; Apostolov V; van Hellenberg Hubar J; Weinstein HC; de Boer JF; Berendse HW
    J Neural Transm (Vienna); 2018 Jun; 125(6):931-936. PubMed ID: 29520613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive Changes in the Retinal Structure of Patients with Parkinson's Disease.
    Ma LJ; Xu LL; Mao CJ; Fu YT; Ji XY; Shen Y; Chen J; Yang YP; Liu CF
    J Parkinsons Dis; 2018; 8(1):85-92. PubMed ID: 29480221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeatability of peripapillary retinal nerve fiber layer and inner retinal thickness among two spectral domain optical coherence tomography devices.
    Matlach J; Wagner M; Malzahn U; Göbel W
    Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6536-46. PubMed ID: 25228545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripapillary retinal nerve fiber layer thickness in a population of 6-year-old children: findings by optical coherence tomography.
    Huynh SC; Wang XY; Rochtchina E; Mitchell P
    Ophthalmology; 2006 Sep; 113(9):1583-92. PubMed ID: 16949443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of structural measurements using 2 Stratus optical coherence tomography instruments.
    Sehi M; Guaqueta DC; Feuer WJ; Greenfield DS
    J Glaucoma; 2007 May; 16(3):287-92. PubMed ID: 17438421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of retinal nerve fibre layer measurements using optical coherence tomography versions 1 and 3 in eyes with band atrophy of the optic nerve and normal controls.
    Monteiro ML; Leal BC; Moura FC; Vessani RM; Medeiros FA
    Eye (Lond); 2007 Jan; 21(1):16-22. PubMed ID: 16311523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis.
    Burkholder BM; Osborne B; Loguidice MJ; Bisker E; Frohman TC; Conger A; Ratchford JN; Warner C; Markowitz CE; Jacobs DA; Galetta SL; Cutter GR; Maguire MG; Calabresi PA; Balcer LJ; Frohman EM
    Arch Neurol; 2009 Nov; 66(11):1366-72. PubMed ID: 19901168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.